Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Posts
- Category: Wall Street Journal (continued)
- Incoming Boston Scientific CEO Plans to Diversify Lineup
- India Brings Heart Surgery to the Masses
- Indian CEO: ‘U.S. Would Grant a Patent to a Piece of Toilet Paper’
- Industry Payments to Surgeons, Revisited
- Industry Pledge to Curb Health Costs May Run Into Legal Troubles
- Industry Promise to Cut Health Costs Wasn’t Easy Sell
- Industry Winners, Losers in Obama Health Care Speech
- Inside the $7 Billion Swine Flu Vaccine Industry
- Inside the Operating Room, We Watch a Hip Replacement
- Insurance Exec: ‘The Consumer View Isn’t Just the Hospital View’
- Insurance Salesman to Obama: Why Are You Vilifying Insurers?
- Insurers Not Committing to End Rescission
- Insurers, Out-of-Network Payments and the New York AG
- InterMune’s Lung Drug Gets Backing From FDA Panel
- Introducing the $30,000 Per Month Cancer Drug
- Investing in Health Care to Invest in Youth
- Iraq Vet Takes New Legs for a Test Run
- Is $1 Billion is the Right Price for Pharma M&A?
- Is a Flawed Health Bill Better Than None?
- Is Banding or Bypass Surgery Best for Obese Teens?
- Is Closing Military Bases a Model for Controlling Medicare Costs?
- Is It Safe to Fix a Hole in the Heart?
- Is the FDA Too Easy On Medical Devices?
- Is the Mediterranean Diet Good for Your Brain?
- Is There a Cure For Cankles?
- It’s Hard to Make Vaccines. Sometimes That’s a Good Thing.
- It’s Official: Peggy Hamburg Will Lead FDA
- It’s Official: Pfizer Pleads Guilty to Illegal Marketing of Bextra
- It’s That Time of Year to Use or Lose Consumer Health Benefits
- J&J and Elan Hear Ticking Sound After Tysabri Court Ruling
- J&J Antes Up $1 Billion for Alzheimer’s Push With Elan
- J&J CEO’s Lower-Risk Alternative to Acquisitions
- J&J Could Try its Hand Selling Branded Generics Abroad
- J&J Rejiggers Salaries, Bonuses to Get in Line With Industry
- J&J, Abbott Earnings: For Pharma, It’s Good to Be Diversified
- J&J’s Annual Sales Fall; First Time Since Depression
- Jackson's Doctor Speaks Out, Posts YouTube Video
- JAMA Conflicts Policy: Now You See It, Now You Don’t
- JAMA Eases Stand on Public Complaints About Conflicts
- Jindal: Obama’s Dishonesty about Health-Care Reform
- Job-Related Drug Tests Show Progress, Mostly
- Jobs Front: Hospital Layoffs Update
- Johns Hopkins Employee May Have Stolen Patient Data
- Joint Commission to Help Hospitals Fix, Not Just Identify, Problems
- Judge’s Sentence for Former Bristol-Myers Exec: Write a Book
- Jury Rules for Hospital That Deported Brain-Injured Patient
- Justice System Struggles with Mentally Ill Kids
- Keep Getting MRSA? Check the Family Pet
- Kellogg: Rice Krispies Won’t Protect Your Kid From Swine Flu
- Kennedy Plan: Health Insurance Mandate, Public Option
- Kermit the Frog’s Conflicts of Interest
- Kerry: Tax on Medical-Device Makers Could Derail Innovation
- Key Republicans Back Obama’s FDA Nominee Peggy Hamburg
- Kids Fool Obesity Researchers, Put Pedometers on Dogs
- Kids Take More Drugs for Diabetes, Attention Deficit
- LA's Pot Entrepreneurs May Go Up in Smoke
- Labor Unites With Big Business On Health Care
- Lawmakers Ask: What If Patients Shared in Medical Decisions?
- Lawmakers Debate Ahead of Obama's Health Speech
- Lawmakers Mull Health-Care Overhaul
- Lawmakers Opt For Smaller Health Care Meetings
- Lawmakers' Health Care Juggles
- Lechleiter: Time We Run Lilly Like a $20 Billion Company
- Less Prevnar May Be Just As Good. Don’t Expect Changes Soon.
- Lilly Gets R&D Chief From Outside. Drugs to Follow?
- Lilly Moves Closer to Another Deal Over Zyprexa Marketing
- Lilly’s Effient: Slow Start for a New Blood Thinner
- Lines to See Most Specialists Get Longer in Boston
- Lipitor & the Era of Mega-Blockbusters. (Also: Fungi.)
- Listing the New Taxes in the Senate Health-Care Bill
- Live Blog: AMA Responds to Obama Speech
- Live Blog: CDC Flu Update
- Live Blog: Haiti Update from Doctors Without Borders
- Live Blog: Swine Flu Update from CDC Chief
- Live Blog: WHO Declares Flu Pandemic
2009 -